Source: Pollen.
  • Tilray (TLRY) has released its Pollen CBD lifestyle brand exclusively on Amazon U.K.
  • The brand includes a line of plant-based CBD gummies and drink drops
  • A wider U.K. rollout is in the works
  • Tilray Brands is a global cannabis and consumer packaged goods company
  • Tilray Stock (TSX:TLRY) is up by 3.7 per cent trading at $5.89 per share

Tilray (TLRY) has released its Pollen CBD lifestyle brand exclusively on Amazon U.K.

Pollen offers a line of CBD gummies in the following varieties:

  • Powerbank, which promotes a natural energy boost with lemon, orange and cacao
  • No Pressure, which reduces everyday stresses with grapefruit, turmeric and cayenne
  • Soothe You, which balances mind and body through a blend of chamomile, honey and cherry

The brand also offers drink drops under the same three names with different flavor profiles:

  • Powerbank features notes of lemon, orange and coffee
  • No Pressure features a punch of blackcurrant
  • Soothe You features hints of grapefruit and raspberry

All Pollen products are plant-based, pesticide-free and designed to uncomplicate wellness routines through high-quality ingredients.

A wider release both online and through local U.K. retailers is forthcoming.

Tilray Brands is a global cannabis and consumer packaged goods company.

More From The Market Online

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.